OPEN Stock: Real Value Emerging or Just a Retail Trap?
OPEN ’s makes selling homes easier by offering fast cash offers. Then, it repairs and resells the homes through its platform. Buyers also complete their purchases online. This digital process…
UPST Favors ((2)) Pullback – Bullish Structure Remains Intact
Upstart Holdings, Inc., (UPST) operates a cloud-based artificial intelligence (AI) lending platform in the United States. The company operates through three segments: Personal lending, Auto lending & others. It comes…
IONQ Stock Analysis: Resuming the Uptrend After a Brief Correction
IONQ Inc., a trailblazer in quantum computing, specializes in developing and manufacturing quantum computers. Founded in 2015 by Christopher Monroe and Jung Sang Kim, the company is based in College…
Robinhood (NASDAQ: HOOD) Enters Wave (III) Final Stage
Robinhood (NASDAQ: HOOD) rallied more than 300% since April 2025 breaking into new all time highs. In our previous article, we explained the bullish sequence taking place within the weekly cycle leading…
TXN Elliott Wave View: Dip Approaches Blue Box Buying Zone
After it completed a 55% rally from April 2025 to July 2025, TXN is correcting the impulse rally. At the extreme of the current pullback, buyers can find new entry.…
CRWD in Final Stage: One More High Could Trigger Market Correction
CrowdStrike (CRWD) leads AI-powered cybersecurity with strong financial results and growing market presence. By mid-2025, its market value passed $104 billion. This shows investor trust, even with ongoing net losses.…
Dow Futures (YM) Resumes Upward Drive in Impulsive Formation
The short-term Elliott Wave analysis for Dow Futures (YM) indicates a cycle from the 1 August 2025 low is forming an impulse. The wave 1 peaked at 45,841, followed by…
SPY Elliott Wave Outlook: Wave (3) Nearing Termination
The short-term Elliott Wave outlook for the S&P 500 ETF (SPY) highlights a cycle starting from the August 1 low. This cycle is unfolding as a diagonal and nears completion.…
Biotech Surge: XBI Ends Correction and Rallies as Expected
The SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities…
